News & SEC Filings

View the latest news and SEC filings

News

LONDON and RALEIGH, N.C., Oct. 06, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to its proposed acquisition by MSD (tradename of Merck &

Transaction expected to close on October 7, 2025 LONDON, U.K., and RALEIGH, N.C., Sept. 24, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, which entered into a definitive agreement on July 8, 2025 relating to

Posters support Ohtuvayre ® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., Sept. 16, 2025 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a biopharmaceutical company focused on

RAHWAY, N.J. & RALEIGH, N.C.–( BUSINESS WIRE )– MSD (tradename of Merck & Co., Inc., Rahway, N.J. USA) and Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a biopharmaceutical company focused on respiratory diseases, today announced that the companies have entered into a

SEC Filings

Date Form Filing Group

March 25, 2021

UPLOAD

UPLOAD

Other

March 25, 2021

EFFECT

EFFECT

Other

March 19, 2021

Simplified registration form

S-3

Registration Statements

March 19, 2021

Post-effective amendment to an S-Type filing

POS AM

Registration Statements

March 19, 2021

Official notification to shareholders of matters to be brought to a vote (“Proxy”)

DEF 14A

Proxy Filings

March 3, 2021

Statement of changes in beneficial ownership of securities

4

3,4,5

March 3, 2021

Statement of changes in beneficial ownership of securities

4

3,4,5

March 3, 2021

Statement of changes in beneficial ownership of securities

4

3,4,5

March 3, 2021

Initial filing by director officer or owner of more than ten percent.

3

3,4,5

Developing novel therapeutics for respiratory diseases

Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.

Close up of female doctor hold woman patient hands help on personal therapy session, psychologist or counselor show understanding and care, support depressed suffering client on treatment